|Articles|January 15, 2020
Catalent Launches FlexDirect
Advertisement
Catalent has announced the launch of FlexDirect, a new direct-to-patient service for clinical trials. The FlexDirect service provides sponsors with the choice of site-to-patient distribution, or Catalent’s new pharmacy-to-patient service.
For more information, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
AstraZeneca’s Phase III POTOMAC Trial Shows Imfinzi Significantly Improves Disease-Free Survival in High-Risk NMIBC
2
Verzenio and Kisqali Deliver Positive Long-Term Results in Early Breast Cancer Trials
3
Accelerating Development Through Parallel Execution and Rigorous Quality Controls
4
Driving Collaboration Across Functions to Streamline Drug Development
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
